National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 1074536

Government Disclaimer on use of this data

Case Details

VAERS ID: 1074536 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Colorado  
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Military       Purchased by: ?
Symptoms: Antibody test, Areflexia, Guillain-Barre syndrome, Lumbar puncture, Plasmapheresis, Sensory loss
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations: AIDP after flu vaccine (Fluzone HD; Sanofi Pasteur; Lot UJ478AA, Exp 6/30/21)
Other Medications: carvedilol 12.5 mg bid, Alprostadil IM PRN for ED, prednisone 10 mg qD, Insulin NPHY 35U qAM, dabigatran 150 mg bid, finasteride 5 mg qD, dulaglutide 1.5 mg qWeek, spironolactone 25 mg qD, Flonase daily PRN, fluconazole 150 mg, tamsulosin
Current Illness:
Preexisting Conditions: Diabetes, HTN, MDD, LE Edema, HFrEF, AFib, OSA, diabetic retinopathy
Allergies: Atorvastatin-$g memory impairment, keflex -$gRash, metoprolol-$g Rash, doxazosin-$g Hypotension
Diagnostic Lab Data: Pending results of LP and ganglioside antibody testing
CDC Split Type:

Write-up: Patient with ascending sensory deficits consistent with AIDP. No weakness or respiratory weakness but areflexic. PLEX started on 3/4. Sensory symptoms stable. Still inpatient

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166